Select Page

InnoSer gets new cell culture facilities.

January 31, 2020

InnoSer is expanding its infrastructure to better its in vitro services. These specialized services include syngeneic oncology models, PBMC and immune population work in vitro/ex vivo, organoid culture, PDX passage work and any in vitro compound screening on fresh tissue from the clinic, cell lines or organoids.

We offer different analysis methods including viability assays, cell proliferation assays, cytokine multiplex, ELISA, and Flow cytometric analyses. We will also have 2 full time research technicians working on the in vitro activities under the guidance of a study director, who is in direct contact with our clients.

If you are interested in learning the details or collaborating with us, please send an email to info@innoserlaboratories.com and we will be happy to answer your questions.

Recent Articles

All Categories

Be the first to know – get this news straight to your inbox

InnoSer provides a variety of validated in vitro and in vivo platforms for the efficient development of novel therapeutics. If you require additional information, feel free to reach out, and we will respond within a few days.

We provide a monthly update from our InnoSer labs containing scientific insights into our research services. To get news straight to your inbox please sign up here.